Compile Data Set for Download or QSAR
maximum 50k data
Found 26 Enz. Inhib. hit(s) with all data for entry = 7876
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222932(US9315500, 2.2)
Affinity DataIC50:  0.600nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222933(US9315500, 2.3)
Affinity DataIC50:  1.10nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222934(US9315500, 2.4)
Affinity DataIC50:  1.30nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222931(US9315500, 2.1)
Affinity DataIC50:  1.60nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222935(US9315500, 2.5)
Affinity DataIC50:  1.60nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222952(US9315500, 3.2)
Affinity DataIC50:  1.80nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222955(US9315500, 1.1)
Affinity DataIC50:  2nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222936(US9315500, 2.6)
Affinity DataIC50:  2nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222953(US9315500, 3.3)
Affinity DataIC50:  2nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222937(US9315500, 2.7)
Affinity DataIC50:  2.10nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222938(US9315500, 2.8)
Affinity DataIC50:  2.30nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222939(US9315500, 2.9)
Affinity DataIC50:  2.70nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222940(US9315500, 2.10)
Affinity DataIC50:  5.20nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222941(US9315500, 2.11)
Affinity DataIC50:  5.40nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222943(US9315500, 2.13)
Affinity DataIC50:  7nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222942(US9315500, 2.12)
Affinity DataIC50:  7nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222944(US9315500, 2.14)
Affinity DataIC50:  8nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222945(US9315500, 2.15)
Affinity DataIC50:  9nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222946(US9315500, 2.16)
Affinity DataIC50:  9nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222951(US9315500, 3.1)
Affinity DataIC50:  9nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222947(US9315500, 2.17)
Affinity DataIC50:  16nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222948(US9315500, 2.18)
Affinity DataIC50:  26nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222954(US9315500, 3.4)
Affinity DataIC50:  32nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222949(US9315500, 2.19)
Affinity DataIC50:  42nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222930(US9315500, 1.2)
Affinity DataIC50:  44nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK [2-635](Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM222950(US9315500, 2.20)
Affinity DataIC50:  45nMpH: 7.5 T: 2°CAssay Description:All assays were performed in 384 well microtiter plates. Each assay plate contained 8-point serial dilutions for 40 test compounds, as well as four 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent